Record-Breaking Price Movement
On 4 Mar 2026, Acutaas Chemicals Ltd achieved a fresh 52-week high, closing at Rs. 2208.15. Despite a day’s decline of 3.09%, the stock’s milestone reflects a significant appreciation from its levels a year ago. The stock opened with a gap down of 2.5%, touching an intraday low of Rs. 2119.8 (-3.26%), yet it remains comfortably above its key moving averages, including the 20-day, 50-day, 100-day, and 200-day averages, signalling sustained underlying strength. However, it currently trades slightly below its 5-day moving average, indicating some short-term consolidation.
Comparative Performance Against Benchmarks
Acutaas Chemicals Ltd has outperformed the broader market indices and its sector peers over multiple time horizons. The stock’s one-year return stands at an impressive 86.26%, vastly exceeding the Sensex’s 7.60% gain over the same period. Year-to-date, the stock has appreciated by 24.68%, while the Sensex has declined by 7.84%. Over the past three months, the stock surged 24.10%, contrasting with the Sensex’s 7.89% fall. Even on a weekly basis, Acutaas Chemicals Ltd’s performance of -1.92% outpaces the Sensex’s -4.54% decline, demonstrating resilience amid broader market volatility.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Strong Fundamentals Underpinning Growth
Acutaas Chemicals Ltd’s ascent to its all-time high is supported by solid financial metrics and operational efficiency. The company boasts a low average Debt to Equity ratio of zero, reflecting a debt-free capital structure that reduces financial risk. Net sales have grown at a compounded annual rate of 26.84%, while operating profit has expanded at an even stronger rate of 38.56%, signalling effective cost management and margin improvement.
Net profit growth has been particularly remarkable, increasing by 47.82% in the latest reported period ending December 2025. This marks the sixth consecutive quarter of positive results, highlighting consistent earnings momentum. The company’s Return on Capital Employed (ROCE) for the half-year period stands at a robust 21.30%, indicating efficient utilisation of capital to generate profits.
Operational efficiency is further demonstrated by the highest inventory turnover ratio of 5.74 times and a debtors turnover ratio of 3.76 times for the half-year, reflecting effective working capital management and strong collection processes.
Institutional Confidence and Market Recognition
Institutional investors hold a significant 38.38% stake in Acutaas Chemicals Ltd, signalling confidence from entities with extensive analytical resources. The company is ranked among the top 1% of all 4,000 stocks rated by MarketsMojo, securing the 6th position among small-cap stocks and 18th across the entire market. Its Mojo Score of 82.0 earned it an upgrade from a Buy to a Strong Buy rating on 6 Oct 2025, reflecting improved quality and growth prospects.
Market Capitalisation and Valuation Metrics
The company holds a Market Cap Grade of 3, indicating a mid-sized market capitalisation within its sector. Despite its strong growth, Acutaas Chemicals Ltd carries a premium valuation, with a Price to Book Value ratio of 12.7 and a Return on Equity (ROE) of 15.8%. The PEG ratio of 0.5 suggests that earnings growth is outpacing the valuation premium, which may be a factor in the stock’s elevated price levels.
Acutaas Chemicals Ltd caught your attention? Explore our comprehensive research report with in-depth analysis of this small-cap Pharmaceuticals & Biotechnology stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth small-cap analysis
- - Valuation assessment included
Long-Term Performance and Sector Context
Over a three-year horizon, Acutaas Chemicals Ltd has delivered a staggering 354.57% return, vastly outperforming the Sensex’s 31.32% gain. This market-beating performance extends to shorter periods as well, with the stock outperforming the BSE500 index over one year and three months. The company operates within the Pharmaceuticals & Biotechnology sector, which has experienced mixed performance recently, making Acutaas Chemicals Ltd’s strong returns particularly noteworthy.
Short-Term Price Dynamics
Despite the all-time high, the stock underperformed its sector by 2.66% on the day of the record price, reflecting some profit-taking or short-term volatility. The one-day performance of -3.09% was slightly worse than the Sensex’s -2.12% decline, indicating that the stock is undergoing a brief correction after its strong rally. Nonetheless, the longer-term trend remains firmly positive.
Summary of Key Financial Metrics
To summarise, Acutaas Chemicals Ltd’s key financial highlights include:
- Net Sales growth at 26.84% CAGR
- Operating Profit growth at 38.56% CAGR
- Net Profit growth of 47.82% in the latest period
- ROCE at 21.30% (half-year)
- Inventory Turnover Ratio at 5.74 times (half-year)
- Debtors Turnover Ratio at 3.76 times (half-year)
- Debt to Equity ratio averaging zero
- Institutional holdings at 38.38%
- Mojo Score of 82.0 with a Strong Buy grade
These metrics collectively illustrate a company with strong growth, efficient capital management, and solid market recognition.
Conclusion
Acutaas Chemicals Ltd’s achievement of a new all-time high at Rs. 2208.15 marks a significant milestone in its market journey. Supported by robust financial performance, strong institutional backing, and consistent earnings growth, the company has demonstrated resilience and strength within the Pharmaceuticals & Biotechnology sector. While short-term price fluctuations are evident, the long-term trend remains decisively positive, reflecting the company’s ability to generate substantial shareholder value over time.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
